NCT02805595View on ClinicalTrials.gov

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

23.4% Hypertonic saline

Saline Injections

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02805595 - Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter